PAA 2.33% 21.0¢ pharmaust limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-154

  1. 1,631 Posts.
    lightbulb Created with Sketch. 575
    Could it possibly be (Please God) that the simple molecule Monepantel (MPL) is not only slowing the progression but like Dr Richard Mollard suggested “ the more MPL, the better the result”. So could it be…….patients on trial…..actually start to slowly recover”……..oh, that would be NICE!!
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 21.0¢ $85.73K 407.4K

Buyers (Bids)

No. Vol. Price($)
2 53482 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 278844 4
View Market Depth
Last trade - 15.15pm 19/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.